Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review
Year: 2026
Type: article
Abstract: In diffuse large B-cell lymphoma, cell and tumor studies show rapamycin can trigger AKT activation via mTORC2; HDAC inhibition may counter this response.
Author: Mondini, Melania
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236600366
